Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | APAF1 | O14727 | 2/20 | 0.31 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9162992 | 0.81 | KMT2A (0.36) | KMT2ADPP4NPC1 | |
| SCHEMBL2197571 | 0.76 | KMT2A (0.35) | KMT2ANPC1 | |
| SCHEMBL8735006 | 0.71 | NPSR1 (0.35) | ALDH1A1KMT2ATGFBR1NPSR1 | |
| SCHEMBL19145900 | 0.70 | KMT2A (0.64) | KMT2ANPC1 | |
| SCHEMBL166209 | 0.70 | KMT2A (0.56) | ALDH1A1KMT2A | |
| SCHEMBL5050835 | 0.69 | GABRR1 (0.47) | TGFBR1NPC1 | |
| SCHEMBL2197438 | 0.69 | KMT2A (0.44) | ALDH1A1KMT2ANPC1 | |
| SCHEMBL19145899 | 0.68 | KMT2A (0.57) | KMT2ANPC1 | |
| SCHEMBL12760921 | 0.67 | KMT2A (0.36) | ALDH1A1KMT2ANPC1 | |
| SCHEMBL10278649 | 0.65 | KMT2A (0.48) | ALDH1A1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773760-B1 | CATALYTIC METHODS FOR THE PRODUCTION OF (METH)ACRYLATES FROM N-HYDROXYALKYLATED AMIDES | BASF SE (DE) | 2017-01-11 | — | — | EP | disclosed |
| US-8263371-B2 | Catalyzed preparation of (meth)acrylates of N-hydroxyalkylated amides | BASF AKTIENGESELLSCHAFT (DE) | 2012-09-11 | — | — | US | disclosed |
| US-7993886-B2 | Catalyzed preparation of (meth)acrylates of N-hydroxyalkylated amides | BASF AKTIENGESELLSHAFT (DE) | 2011-08-09 | — | — | US | disclosed |
| US-20110171697-A1 | CATALYZED PREPARATION OF (METH)ACRYLATES OF N-HYDROXYALKYLATED AMIDES | BASF AKTIENGESELLSHAFT (DE) | 2011-07-14 | — | — | US | disclosed |
| US-20100285542-A1 | CATALYZED PREPARATION OF (METH)ACRYLATES OF N-HYDROXYALKYLATED AMIDES | BASF AKTIENGESELLSHAFT (DE) | 2010-11-11 | — | — | US | disclosed |
| US-7816485-B2 | Catalyzed preparation of (meth)acrylates of N-hydroxyalkylated amides | BASF AKTIENGESELLSCHAFT (DE) | 2010-10-19 | — | — | US | disclosed |
| EP-1773760-A1 | CATALYTIC METHODS FOR THE PRODUCTION OF (METH)ACRYLATES FROM N-HYDROXYALKYLATED AMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-18 | — | — | EP | disclosed |
| US-20060036063-A1 | Catalyzed preparation of (meth)acrylates of N-hydroxyalkylated amides | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-16 | — | — | US | disclosed |
| WO-2006012980-A1 | CATALYTIC METHODS FOR THE PRODUCTION OF (METH)ACRYLATES FROM N-HYDROXYALKYLATED AMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100285542-A1 | CATALYZED PREPARATION OF (METH)ACRYLATES OF N-HYDROXYALKYLATED AMIDES | NAAA, APEH, NAA15 | ALDH1A1 118/4885KMT2A 518/4885APAF1 3464/4885 |
| US-20110171697-A1 | CATALYZED PREPARATION OF (METH)ACRYLATES OF N-HYDROXYALKYLATED AMIDES | NAAA, APEH, NAA15 | ALDH1A1 118/4885KMT2A 518/4885APAF1 3464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.